Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01076452 · ClinicalTrials.gov registry record · Phase 3
Phase II Subthalamic Nucleus (STN) vs. Globus Pallidus (GPi) Trial
A Phase 3 study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Phase 3
- Development phase
- 299
- Enrollment target
NCT01076452 is a Phase 3 study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 299 participants.
The verdict
NCT01076452, a Phase 3 study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 299 participants
- Enrollment target
Study Summary
The goal of the second phase of the study is to determine if simultaneous bilateral subthalamic nucleus stimulation or simultaneous bilateral globus pallidus stimulation is more effective in reducing symptoms of Parkinson's Disease.
Interventions
- DEVICE Bilateral Deep Brain Stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 299 participants |
| Start Date | 2002-04 |
| Est. Completion | 2009-04 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01076452
The ClinicalTrials.gov registry entry for NCT01076452 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 299 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Bilateral Deep Brain Stimulation is the first listed.
NCT01076452 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01076452 about?
NCT01076452 is a clinical study titled "Phase II Subthalamic Nucleus (STN) vs. Globus Pallidus (GPi) Trial". The goal of the second phase of the study is to determine if simultaneous bilateral subthalamic nucleus stimulation or simultaneous bilateral globus pallidus stimulation is more effective in reducing symptoms of Parkinson's Disease.
What is the current status of trial NCT01076452?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 299 participants. The study started on 2002-04. Estimated completion is 2009-04.
What interventions are being tested in trial NCT01076452?
The interventions under investigation include: Bilateral Deep Brain Stimulation (DEVICE).
Who is sponsoring clinical trial NCT01076452?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.